SCHEMBL480735

SCHEMBL480735

CC(=O)Nc1nc(-c2ccc(C(F)(F)F)c(F)c2)cs1

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 7/20 0.70
RAB9A P51151 4/20 0.60
NPC1 O15118 3/20 0.60
ALDH1A1 P00352 2/20 0.58
HSD17B10 Q99714 2/20 0.58
MEN1 O00255 1/20 0.58
ALOX15 P16050 1/20 0.58
MAPK1 P28482 1/20 0.58
KMT2A Q03164 1/20 0.58
MPL P40238 1/20 0.57
TRPA1 O75762 7/20 0.56
TRPV4 Q9HBA0 4/20 0.56
HPGD P15428 1/20 0.54
HTT P42858 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17400523 0.90 ABL1 (0.70) ABL1RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL16254980 0.86 ABL1 (0.79) ABL1RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL19448234 0.85 ABL1 (0.65) ABL1RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL480598 0.85 TRPA1 (0.61) ABL1RAB9ANPC1MEN1KMT2A
SCHEMBL17400600 0.84 ABL1 (0.73) ABL1RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL19448232 0.84 ABL1 (0.59) ABL1RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL30439830 0.82 MEN1 (0.74) ABL1RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL18691881 0.82 MEN1 (0.74) ABL1RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL18724276 0.81 ABL1 (0.56) ABL1RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL18724077 0.80 ALDH1A1 (0.60) ABL1RAB9ANPC1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411393-A1 FUSED PYRIMIDINE-DIONE DERIVATIVES AS TRPA1 MODULATORS Glenmark Pharmaceuticals S.A. (CH) 2012-02-01 EP disclosed
WO-2010109287-A1 FUSED PYRIMIDINE-DIONE DERIVATIVES AS TRPA1 MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2010-09-30 WO disclosed